Scientists are calling Plexxikon’s experimental skin cancer drug a “breakthrough” after it successfully shrank tumors in clinical trial patients.
Browsing: electro optical sciences
Electro-Optical Sciences anounced that it has submitted a Premarket Approval Application to the U.S. Food and Drug Administration for MelaFind.
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.